Richardson M A, Smith D R, Kemp D H, Tellam R L
Biotech Australia Pty Ltd, Roseville, New South Wales, Australia.
Insect Mol Biol. 1993;1(3):139-47. doi: 10.1111/j.1365-2583.1993.tb00115.x.
A glycoprotein (BM86) from the gut cells of the cattle tick Boophilus microplus, when used to vaccinate cattle, has been shown to protect cattle from tick infestation. A recombinant BM86 protein is the principal component of a novel tick vaccine currently under development. The nature of the anchorage of BM86 to tick gut epithelial cells has been investigated using BM86 from B. microplus and recombinant BM86 proteins expressed in insect cells using the baculovirus expression system. BM86 from B. microplus and a full length recombinant BM86 are shown to be anchored to the extracellular surface of tick gut epithelial cells and baculovirus-infected insect cells, respectively by a glycosyl-phosphatidyl inositol membrane anchor. A recombinant BM86 truncated by the removal of a hydrophobic region coding for thirty amino acids at the carboxy-terminal end was secreted from baculovirus-infected Sf9 cells. This secreted form of recombinant BM86 showed strong protective activity against ticks in cattle vaccinated with this protein.
微小牛蜱肠道细胞中的一种糖蛋白(BM86),用于给牛接种疫苗时,已显示能保护牛免受蜱虫侵扰。一种重组BM86蛋白是目前正在研发的新型蜱虫疫苗的主要成分。利用微小牛蜱的BM86和使用杆状病毒表达系统在昆虫细胞中表达的重组BM86蛋白,研究了BM86与蜱虫肠道上皮细胞的锚定性质。微小牛蜱的BM86和全长重组BM86分别通过糖基磷脂酰肌醇膜锚定在蜱虫肠道上皮细胞和杆状病毒感染的昆虫细胞的细胞外表面。通过去除羧基末端编码30个氨基酸的疏水区域而截短的重组BM86从杆状病毒感染的Sf9细胞中分泌出来。这种分泌形式的重组BM86在用该蛋白接种疫苗的牛中显示出对蜱虫的强大保护活性。